NCT00544830View on ClinicalTrials.gov

Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

July 18, 2006

Primary Completion Date

March 16, 2011

Study Completion Date

March 9, 2026

Conditions
PSA Level Greater Than TwoStage IV Prostate Adenocarcinoma AJCC v7
Interventions
DRUG

Bicalutamide

Given PO

DRUG

Goserelin Acetate

Given SC

RADIATION

Intensity-Modulated Radiation Therapy

Undergo IMRT

OTHER

Laboratory Biomarker Analysis

Correlative studies

DRUG

Leuprolide Acetate

Given via injection

Trial Locations (2)

91010

City of Hope Medical Center, Duarte

91030

City of Hope South Pasadena, South Pasadena

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER